✦ LIBER ✦

Mouse models of cancers: opportunities to address heterogeneity of human cancer and evaluate therapeutic strategies

✍ Scribed by Eran R. Andrechek; Joseph R. Nevins

Publisher: Springer
Year: 2010
Tongue: English
Weight: 324 KB
Volume: 88
Category: Article
ISSN: 0946-2716
DOI: 10.1007/s00109-010-0644-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The Relevance of Mouse Models to Underst

The Relevance of Mouse Models to Understanding the Development and Progression of Human Breast Cancer

✍ D. Craig Allred; Daniel Medina 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 366 KB

Therapeutic efficacy of once-daily oral

Therapeutic efficacy of once-daily oral administration of a Kunitz-type protease inhibitor, bikunin, in a mouse model and in human cancer

✍ Hiroshi Kobayashi; Tatsuo Yagyu; Kiyokazu Inagaki; Toshiharu Kondo; Mika Suzuki; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 244 KB

## Abstract ## BACKGROUND Bikunin, a Kunitz‐type protease inhibitor, specifically inhibits tumor invasion and metastasis. ## METHODS The authors initially evaluated the therapeutic efficacy of once‐daily oral administration of different doses of bikunin against human ovarian carcinoma HRA cells

Curcumin sensitizes human colorectal can

Curcumin sensitizes human colorectal cancer to capecitabine by modulation of cyclin D1, COX-2, MMP-9, VEGF and CXCR4 expression in an orthotopic mouse model

✍ Ajaikumar B. Kunnumakkara; Parmeswaran Diagaradjane; Preetha Anand; Harikumar B. 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 635 KB

## Abstract Because of the poor prognosis and the development of resistance against chemotherapeutic drugs, the current treatment for advanced metastatic colorectal cancer (CRC) is ineffective. Whether curcumin (a component of turmeric) can potentiate the effect of capecitabine against growth and m

Therapeutic efficacy and dose-limiting t

Therapeutic efficacy and dose-limiting toxicity of auger-electron vs. beta emitters in radioimmunotherapy with internalizing antibodies: Evaluation of 125I- vs. 131I-labeled CO17-1A in a human colorectal cancer model

✍ Thomas M. Behr; George Sgouros; Vassilios Vougioukas; Stavros Memtsoudis; Stefan 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 187 KB

Recent clinical results suggest that higher anti-tumor efficacy may be achieved with internalizing monoclonal antibodies (MAbs) at lower toxicity when labeled with Augerelectron, as compared to conventional ␤-emitters. The aim of our study was to compare the toxicity and anti-tumor efficacy of the 1

Humans and their animal models. “The rel

Humans and their animal models. “The relevance of animal studies to the evaluation of human cancer risk,” R. D'Amato, T.J. Slaga, W.H. Farland, and C. Henry (eds). New York: Wiley-Liss, 1992, 457 pp, $125.00

✍ Anthony B. Deangelo 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB